195 related articles for article (PubMed ID: 30561796)
1. Ovarian cancer risk factors by tumor aggressiveness: An analysis from the Ovarian Cancer Cohort Consortium.
Fortner RT; Poole EM; Wentzensen NA; Trabert B; White E; Arslan AA; Patel AV; Setiawan VW; Visvanathan K; Weiderpass E; Adami HO; Black A; Bernstein L; Brinton LA; Buring J; Clendenen TV; Fournier A; Fraser G; Gapstur SM; Gaudet MM; Giles GG; Gram IT; Hartge P; Hoffman-Bolton J; Idahl A; Kaaks R; Kirsh VA; Knutsen S; Koh WP; Lacey JV; Lee IM; Lundin E; Merritt MA; Milne RL; Onland-Moret NC; Peters U; Poynter JN; Rinaldi S; Robien K; Rohan T; Sánchez MJ; Schairer C; Schouten LJ; Tjonneland A; Townsend MK; Travis RC; Trichopoulou A; van den Brandt PA; Vineis P; Wilkens L; Wolk A; Yang HP; Zeleniuch-Jacquotte A; Tworoger SS
Int J Cancer; 2019 Jul; 145(1):58-69. PubMed ID: 30561796
[TBL] [Abstract][Full Text] [Related]
2. Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium.
Wentzensen N; Poole EM; Trabert B; White E; Arslan AA; Patel AV; Setiawan VW; Visvanathan K; Weiderpass E; Adami HO; Black A; Bernstein L; Brinton LA; Buring J; Butler LM; Chamosa S; Clendenen TV; Dossus L; Fortner R; Gapstur SM; Gaudet MM; Gram IT; Hartge P; Hoffman-Bolton J; Idahl A; Jones M; Kaaks R; Kirsh V; Koh WP; Lacey JV; Lee IM; Lundin E; Merritt MA; Onland-Moret NC; Peters U; Poynter JN; Rinaldi S; Robien K; Rohan T; Sandler DP; Schairer C; Schouten LJ; Sjöholm LK; Sieri S; Swerdlow A; Tjonneland A; Travis R; Trichopoulou A; van den Brandt PA; Wilkens L; Wolk A; Yang HP; Zeleniuch-Jacquotte A; Tworoger SS
J Clin Oncol; 2016 Aug; 34(24):2888-98. PubMed ID: 27325851
[TBL] [Abstract][Full Text] [Related]
3. Hormonal and reproductive risk factors for epithelial ovarian cancer by tumor aggressiveness.
Poole EM; Merritt MA; Jordan SJ; Yang HP; Hankinson SE; Park Y; Rosner B; Webb PM; Cramer DW; Wentzensen N; Terry KL; Tworoger SS
Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):429-37. PubMed ID: 23307531
[TBL] [Abstract][Full Text] [Related]
4. Reproductive and hormone-related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: Results from the EPIC cohort.
Fortner RT; Ose J; Merritt MA; Schock H; Tjønneland A; Hansen L; Overvad K; Dossus L; Clavel-Chapelon F; Baglietto L; Boeing H; Trichopoulou A; Benetou V; Lagiou P; Agnoli C; Mattiello A; Masala G; Tumino R; Sacerdote C; Bueno-de-Mesquita HB; Onland-Moret NC; Peeters PH; Weiderpass E; Torhild Gram I; Duell EJ; Larrañaga N; Ardanaz E; Sánchez MJ; Chirlaque MD; Brändstedt J; Idahl A; Lundin E; Khaw KT; Wareham N; Travis RC; Rinaldi S; Romieu I; Gunter MJ; Riboli E; Kaaks R
Int J Cancer; 2015 Sep; 137(5):1196-208. PubMed ID: 25656413
[TBL] [Abstract][Full Text] [Related]
5. Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: A Mendelian randomization analysis.
Yarmolinsky J; Relton CL; Lophatananon A; Muir K; Menon U; Gentry-Maharaj A; Walther A; Zheng J; Fasching P; Zheng W; Yin Ling W; Park SK; Kim BG; Choi JY; Park B; Davey Smith G; Martin RM; Lewis SJ
PLoS Med; 2019 Aug; 16(8):e1002893. PubMed ID: 31390370
[TBL] [Abstract][Full Text] [Related]
6. Histological subtypes of ovarian cancer associated with parity and breastfeeding in the prospective Million Women Study.
Gaitskell K; Green J; Pirie K; Barnes I; Hermon C; Reeves GK; Beral V;
Int J Cancer; 2018 Jan; 142(2):281-289. PubMed ID: 28929490
[TBL] [Abstract][Full Text] [Related]
7. Endogenous androgens and risk of epithelial invasive ovarian cancer by tumor characteristics in the European Prospective Investigation into Cancer and Nutrition.
Ose J; Fortner RT; Rinaldi S; Schock H; Overvad K; Tjonneland A; Hansen L; Dossus L; Fournier A; Baglietto L; Romieu I; Kuhn E; Boeing H; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Masala G; Sieri S; Tumino R; Sacerdote C; Mattiello A; Ramon Quiros J; Obón-Santacana M; Larrañaga N; Chirlaque MD; Sánchez MJ; Barricarte A; Peeters PH; Bueno-de-Mesquita HB; Onland-Moret NC; Brändstedt J; Lundin E; Idahl A; Weiderpass E; Gram IT; Lund E; Kaw KT; Travis RC; Merritt MA; Gunther MJ; Riboli E; Kaaks R
Int J Cancer; 2015 Jan; 136(2):399-410. PubMed ID: 24890047
[TBL] [Abstract][Full Text] [Related]
8. The association of reproductive factors with risk of non-epithelial ovarian cancer and comparison with serous ovarian cancer.
Hemmingsen CH; Kjaer SK; Bennetsen AKK; Dehlendorff C; Baandrup L
Gynecol Oncol; 2021 Aug; 162(2):469-474. PubMed ID: 34016454
[TBL] [Abstract][Full Text] [Related]
9. Joint exposure to smoking, excessive weight, and physical inactivity and survival of ovarian cancer patients, evidence from the Ovarian Cancer Association Consortium.
Minlikeeva AN; Cannioto R; Jensen A; Kjaer SK; Jordan SJ; Diergaarde B; Szender JB; Odunsi K; Almohanna H; Mayor P; Starbuck K; Zsiros E; Bandera EV; Cramer DW; Doherty JA; DeFazio A; ; Edwards R; Goode EL; Goodman MT; Høgdall E; Matsuo K; Mizuno M; Nagle CM; Ness RB; Paddock LE; Pearce CL; Risch HA; Rossing MA; Terry KL; Wu AH; Modugno F; Webb PM; Moysich KB;
Cancer Causes Control; 2019 May; 30(5):537-547. PubMed ID: 30905014
[TBL] [Abstract][Full Text] [Related]
10. Histological Tumor Type is Associated with One-Year Cause-Specific Survival in Women with Stage III-IV Epithelial Ovarian Cancer: A Surveillance, Epidemiology, and End Results (SEER) Database Population Study, 2004-2014.
Wu SG; Li FY; Lei J; Hua L; He ZY; Zhou J
Med Sci Monit; 2020 Feb; 26():e920531. PubMed ID: 32008036
[TBL] [Abstract][Full Text] [Related]
11. Prediagnosis and postdiagnosis smoking and survival following diagnosis with ovarian cancer.
Wang T; Townsend MK; Simmons V; Terry KL; Matulonis UA; Tworoger SS
Int J Cancer; 2020 Aug; 147(3):736-746. PubMed ID: 31693173
[TBL] [Abstract][Full Text] [Related]
12. Cigarette smoking and risk of histological subtypes of epithelial ovarian cancer in the EPIC cohort study.
Gram IT; Lukanova A; Brill I; Braaten T; Lund E; Lundin E; Overvad K; Tjønneland A; Clavel-Chapelon F; Chabbert-Buffet N; Bamia C; Trichopoulou A; Zylis D; Masala G; Berrino F; Galasso R; Tumino R; Sacerdote C; Gavrilyuk O; Kristiansen S; Rodríguez L; Bonet C; Huerta JM; Barricarte A; Sánchez MJ; Dorronsoro M; Jirström K; Almquist M; Idahl A; Bueno-de-Mesquita HB; Braem M; Onland-Moret C; Tsilidis KK; Allen NE; Fedirko V; Riboli E; Kaaks R
Int J Cancer; 2012 May; 130(9):2204-10. PubMed ID: 21678398
[TBL] [Abstract][Full Text] [Related]
13. Expanding Our Understanding of Ovarian Cancer Risk: The Role of Incomplete Pregnancies.
Lee AW; Rosenzweig S; Wiensch A; ; Ramus SJ; Menon U; Gentry-Maharaj A; Ziogas A; Anton-Culver H; Whittemore AS; Sieh W; Rothstein JH; McGuire V; Wentzensen N; Bandera EV; Qin B; Terry KL; Cramer DW; Titus L; Schildkraut JM; Berchuck A; Goode EL; Kjaer SK; Jensen A; Jordan SJ; Ness RB; Modugno F; Moysich K; Thompson PJ; Goodman MT; Carney ME; Chang-Claude J; Rossing MA; Harris HR; Doherty JA; Risch HA; Khoja L; Alimujiang A; Phung MT; Brieger K; Mukherjee B; Pharoah PDP; Wu AH; Pike MC; Webb PM; Pearce CL
J Natl Cancer Inst; 2021 Mar; 113(3):301-308. PubMed ID: 32766851
[TBL] [Abstract][Full Text] [Related]
14. The Risk of Ovarian Cancer Increases with an Increase in the Lifetime Number of Ovulatory Cycles: An Analysis from the Ovarian Cancer Cohort Consortium (OC3).
Trabert B; Tworoger SS; O'Brien KM; Townsend MK; Fortner RT; Iversen ES; Hartge P; White E; Amiano P; Arslan AA; Bernstein L; Brinton LA; Buring JE; Dossus L; Fraser GE; Gaudet MM; Giles GG; Gram IT; Harris HR; Bolton JH; Idahl A; Jones ME; Kaaks R; Kirsh VA; Knutsen SF; Kvaskoff M; Lacey JV; Lee IM; Milne RL; Onland-Moret NC; Overvad K; Patel AV; Peters U; Poynter JN; Riboli E; Robien K; Rohan TE; Sandler DP; Schairer C; Schouten LJ; Setiawan VW; Swerdlow AJ; Travis RC; Trichopoulou A; van den Brandt PA; Visvanathan K; Wilkens LR; Wolk A; Zeleniuch-Jacquotte A; Wentzensen N;
Cancer Res; 2020 Mar; 80(5):1210-1218. PubMed ID: 31932455
[TBL] [Abstract][Full Text] [Related]
15. Trends and characteristics of epithelial ovarian cancer in Japan between 2002 and 2015: A JSGO-JSOG joint study.
Machida H; Matsuo K; Yamagami W; Ebina Y; Kobayashi Y; Tabata T; Kanauchi M; Nagase S; Enomoto T; Mikami M
Gynecol Oncol; 2019 Jun; 153(3):589-596. PubMed ID: 30905436
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Survival Among Histological Subtypes in Advanced Epithelial Ovarian Cancer: Population-Based Study Using the Surveillance, Epidemiology, and End Results Database.
Yang SP; Su HL; Chen XB; Hua L; Chen JX; Hu M; Lei J; Wu SG; Zhou J
JMIR Public Health Surveill; 2021 Nov; 7(11):e25976. PubMed ID: 34787583
[TBL] [Abstract][Full Text] [Related]
17. Smoking and risk of ovarian cancer by histological subtypes: an analysis among 300 000 Norwegian women.
Licaj I; Jacobsen BK; Selmer RM; Maskarinec G; Weiderpass E; Gram IT
Br J Cancer; 2017 Jan; 116(2):270-276. PubMed ID: 27959888
[TBL] [Abstract][Full Text] [Related]
18. Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage.
Peres LC; Cushing-Haugen KL; Köbel M; Harris HR; Berchuck A; Rossing MA; Schildkraut JM; Doherty JA
J Natl Cancer Inst; 2019 Jan; 111(1):60-68. PubMed ID: 29718305
[TBL] [Abstract][Full Text] [Related]
19. Pelvic inflammatory disease and risk of epithelial ovarian cancer: a national population-based case-control study in Sweden.
Jonsson S; Jonsson H; Lundin E; Häggström C; Idahl A
Am J Obstet Gynecol; 2024 Jan; 230(1):75.e1-75.e15. PubMed ID: 37778677
[TBL] [Abstract][Full Text] [Related]
20. Ovarian cancer and smoking: individual participant meta-analysis including 28,114 women with ovarian cancer from 51 epidemiological studies.
; Beral V; Gaitskell K; Hermon C; Moser K; Reeves G; Peto R
Lancet Oncol; 2012 Sep; 13(9):946-56. PubMed ID: 22863523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
